Position
Fidelity in LENZ Therapeutics, Inc.
Back to the book · All holders of LENZ
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$12.3M$9.15 → $5.68
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 3.7M | $59.2M | — | — | — | 0.0% |
| Q1 2026 | 3.6M | $32.9M | $9.15 | −$24.6M | −$1.68M | 0.0% |
| Q2 2026 | 3.56M | $20.2M | $5.68 | −$12.3M | −$355.7K | 0.0% |